Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Almeida

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Haematologica|March 15, 2006
Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: biclonality versus intraclonal evolution of a single tumor cell cloneMaria Luz Sanchez, Julia Almeida, Antonio Lopez, et al.
Cancers|January 8, 2023
Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL SubjectsIgnacio Criado, Wendy G Nieto, Guillermo Oliva-Ariza, et al.
Oncotarget|February 4, 2016
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapyLourdes Martín-Martín, Julia Almeida, Helena Pomares, et al.
Frontiers in Oncology|November 12, 2021
The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct OutcomeArancha Rodríguez-Caballero, Blanca Fuentes Herrero, Guillermo Oliva Ariza, et al.
British Journal of Haematology|August 30, 2002
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survivalMaria V Mateos, Ramón García-Sanz, Ricardo López-Pérez, et al.
Cancers|February 13, 2025
Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0Fernando Solano, Ignacio Criado, Nahir Moreno, et al.
Blood|June 3, 2006
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patientsAndres C Garcia-Montero, Maria Jara-Acevedo, Cristina Teodosio, et al.
Cancers|September 10, 2021
Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic ImplementationNoemí Muñoz-García, Margarida Lima, Neus Villamor, et al.
Journal of Translational Medicine|November 22, 2025
Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysisGerardo J Martí-Chillón, Sandra Muntión, Juan Flores-Montero, et al.
International Journal of Cancer|November 13, 2008
Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the diseaseMartin Perez-Andres, Julia Almeida, Marta Martin-Ayuso, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Haematologica|March 15, 2006
Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: biclonality versus intraclonal evolution of a single tumor cell cloneMaria Luz Sanchez, Julia Almeida, Antonio Lopez, et al.
Cancers|January 8, 2023
Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL SubjectsIgnacio Criado, Wendy G Nieto, Guillermo Oliva-Ariza, et al.
Oncotarget|February 4, 2016
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapyLourdes Martín-Martín, Julia Almeida, Helena Pomares, et al.
Frontiers in Oncology|November 12, 2021
The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct OutcomeArancha Rodríguez-Caballero, Blanca Fuentes Herrero, Guillermo Oliva Ariza, et al.
British Journal of Haematology|August 30, 2002
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survivalMaria V Mateos, Ramón García-Sanz, Ricardo López-Pérez, et al.
Cancers|February 13, 2025
Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0Fernando Solano, Ignacio Criado, Nahir Moreno, et al.
Blood|June 3, 2006
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patientsAndres C Garcia-Montero, Maria Jara-Acevedo, Cristina Teodosio, et al.
Cancers|September 10, 2021
Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic ImplementationNoemí Muñoz-García, Margarida Lima, Neus Villamor, et al.
Journal of Translational Medicine|November 22, 2025
Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysisGerardo J Martí-Chillón, Sandra Muntión, Juan Flores-Montero, et al.
International Journal of Cancer|November 13, 2008
Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the diseaseMartin Perez-Andres, Julia Almeida, Marta Martin-Ayuso, et al.
Pageof 12